266 related articles for article (PubMed ID: 26874554)
1. Assessment of voice, speech, and related quality of life in advanced head and neck cancer patients 10-years+ after chemoradiotherapy.
Kraaijenga SA; Oskam IM; van Son RJ; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW; van der Molen L
Oral Oncol; 2016 Apr; 55():24-30. PubMed ID: 26874554
[TBL] [Abstract][Full Text] [Related]
2. Pre- and posttreatment voice and speech outcomes in patients with advanced head and neck cancer treated with chemoradiotherapy: expert listeners' and patient's perception.
van der Molen L; van Rossum MA; Jacobi I; van Son RJ; Smeele LE; Rasch CR; Hilgers FJ
J Voice; 2012 Sep; 26(5):664.e25-33. PubMed ID: 22209059
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of long term (10-years+) dysphagia and trismus in patients treated with concurrent chemo-radiotherapy for advanced head and neck cancer.
Kraaijenga SA; Oskam IM; van der Molen L; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW
Oral Oncol; 2015 Aug; 51(8):787-94. PubMed ID: 26027851
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported voice and speech outcomes after whole-neck intensity modulated radiation therapy and chemotherapy for oropharyngeal cancer: prospective longitudinal study.
Vainshtein JM; Griffith KA; Feng FY; Vineberg KA; Chepeha DB; Eisbruch A
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):973-980. PubMed ID: 24803039
[TBL] [Abstract][Full Text] [Related]
5. Prospective clinical study on long-term swallowing function and voice quality in advanced head and neck cancer patients treated with concurrent chemoradiotherapy and preventive swallowing exercises.
Kraaijenga SA; van der Molen L; Jacobi I; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW
Eur Arch Otorhinolaryngol; 2015 Nov; 272(11):3521-31. PubMed ID: 25381096
[TBL] [Abstract][Full Text] [Related]
6. Speech and voice outcomes in oropharyngeal cancer and evaluation of the University of Washington Quality of Life speech domain.
Thomas L; Jones TM; Tandon S; Carding P; Lowe D; Rogers S
Clin Otolaryngol; 2009 Feb; 34(1):34-42. PubMed ID: 19260883
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of swallowing and speech problems in daily life after chemoradiation for head and neck cancer based on cut-off scores of the patient-reported outcome measures SWAL-QOL and SHI.
Rinkel RN; Verdonck-de Leeuw IM; Doornaert P; Buter J; de Bree R; Langendijk JA; Aaronson NK; Leemans CR
Eur Arch Otorhinolaryngol; 2016 Jul; 273(7):1849-55. PubMed ID: 26071622
[TBL] [Abstract][Full Text] [Related]
8. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
[TBL] [Abstract][Full Text] [Related]
9. Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy.
Chen AM; Daly ME; Farwell DG; Vazquez E; Courquin J; Lau DH; Purdy JA
JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):129-33. PubMed ID: 24337483
[TBL] [Abstract][Full Text] [Related]
10. A single-institutional experience of 15 years of treating T3 laryngeal cancer with primary radiotherapy, with or without chemotherapy.
Al-Mamgani A; Tans L; van Rooij P; Levendag PC
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1000-6. PubMed ID: 22099030
[TBL] [Abstract][Full Text] [Related]
11. Development of the German Speech Intelligibility Index for the treatment of oral cancer patients.
Bachmann AS; Wiltfang J; Hertrampf K
J Craniomaxillofac Surg; 2021 Jan; 49(1):52-58. PubMed ID: 33281030
[TBL] [Abstract][Full Text] [Related]
12. Communication changes following non-glottic head and neck cancer management: The perspectives of survivors and carers.
Nund RL; Rumbach AF; Debattista BC; Goodrow MN; Johnson KA; Tupling LN; Scarinci NA; Cartmill B; Ward EC; Porceddu SV
Int J Speech Lang Pathol; 2015 Jun; 17(3):263-72. PubMed ID: 25764915
[TBL] [Abstract][Full Text] [Related]
13. Impact of Chemoradiation After Supra- or Infrahyoid Cancer on Aerodynamic, Subjective, and Objective Voice Assessments: A Multicenter Prospective Study.
Lechien JR; Khalife M; Huet K; Fourneau AF; Delvaux V; Piccaluga M; Harmegnies B; Saussez S
J Voice; 2018 Mar; 32(2):257.e11-257.e19. PubMed ID: 28527541
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome and morbidity after treatment with accelerated radiotherapy and weekly cisplatin for locally advanced head-and-neck cancer: results of a multidisciplinary late morbidity clinic.
Rütten H; Pop LA; Janssens GO; Takes RP; Knuijt S; Rooijakkers AF; van den Berg M; Merkx MA; van Herpen CM; Kaanders JH
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):923-9. PubMed ID: 21095074
[TBL] [Abstract][Full Text] [Related]
15. Late toxicity after radical treatment for locally advanced head and neck cancer.
Taberna M; Rullan AJ; Hierro C; Navarro V; Vázquez S; Lozano A; Vilajosana E; Maños M; Marí A; Viñals J; Mesía R
Oral Oncol; 2015 Aug; 51(8):795-9. PubMed ID: 26051499
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer.
Han K; Cummings BJ; Lindsay P; Skliarenko J; Craig T; Le LW; Brierley J; Wong R; Dinniwell R; Bayley AJ; Dawson LA; Ringash J; Krzyzanowska MK; Moore MJ; Chen EX; Easson AM; Kassam Z; Cho C; Kim J
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):587-94. PubMed ID: 25194664
[TBL] [Abstract][Full Text] [Related]
17. Voice-related Quality of Life in laryngectomees: assessment using the VHI and V-RQOL symptom scales.
Kazi R; De Cordova J; Singh A; Venkitaraman R; Nutting CM; Clarke P; Rhys-Evans P; Harrington KJ
J Voice; 2007 Nov; 21(6):728-34. PubMed ID: 16815670
[TBL] [Abstract][Full Text] [Related]
18. Voice outcomes after concurrent chemoradiotherapy for advanced nonlaryngeal head and neck cancer: a prospective study.
Paleri V; Carding P; Chatterjee S; Kelly C; Wilson JA; Welch A; Drinnan M
Head Neck; 2012 Dec; 34(12):1747-52. PubMed ID: 22319013
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.
Falchook AD; Green R; Knowles ME; Amdur RJ; Mendenhall W; Hayes DN; Grilley-Olson JE; Weiss J; Reeve BB; Mitchell SA; Basch EM; Chera BS
JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):517-23. PubMed ID: 27149571
[TBL] [Abstract][Full Text] [Related]
20. Five-year quality of life results of the randomized clinical phase III (RADPLAT) trial, comparing concomitant intra-arterial versus intravenous chemoradiotherapy in locally advanced head and neck cancer.
Ackerstaff AH; Rasch CR; Balm AJ; de Boer JP; Wiggenraad R; Rietveld DH; Gregor RT; Kröger R; Hauptmann M; Vincent A; Hilgers FJ
Head Neck; 2012 Jul; 34(7):974-80. PubMed ID: 21818820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
